Rezolute (RZLT) Retained Earnings (2011 - 2026)
Rezolute's (RZLT) quarterly Retained Earnings came in at -$115000.0 in Q1 2026, down 367.44% year-on-year from $43000.0 in Q1 2025, and up 99.97% quarter-over-quarter from -$444.8 million in Q4 2025.
Rezolute (RZLT) Retained Earnings (2011 - 2026) Analysis & Trends
Rezolute has disclosed Retained Earnings across 16 years of filings, most recently posting -$115000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$115000.0, down 367.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$115000.0 (down 367.44% YoY), and the FY2025 annual result was -$7000.0, up 100.0% from the prior year.
- Retained Earnings came in at -$115000.0 for Q1 2026 at Rezolute, up from -$444.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $289000.0 in Q3 2024 to a low of -$444.8 million in Q4 2025.
- The 5-year median for Retained Earnings is -$209.2 million (2022), against an average of -$174.9 million.
- Peak annual rise in Retained Earnings reached 201.76% in 2024, while the deepest fall reached 751050.0% in 2024.
- Rezolute's Retained Earnings stood at -$232.6 million in 2022, then surged by 99.98% to -$48000.0 in 2023, then tumbled by 751050.0% to -$360.6 million in 2024, then dropped by 23.36% to -$444.8 million in 2025, then soared by 99.97% to -$115000.0 in 2026.
- The last three Retained Earnings figures came in at -$115000.0 (Q1 2026), -$444.8 million (Q4 2025), and -$422.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115,000.00 |
| Dec 31, 2025 | -444.78 Mn |
| Sep 30, 2025 | -422.00 Mn |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | -360.55 Mn |
| Sep 30, 2024 | 289,000.00 |
| Jun 30, 2024 | -329.44 Mn |
| Mar 31, 2024 | -306.50 Mn |
| Dec 31, 2023 | -48,000.00 |
| Sep 30, 2023 | -284,000.00 |
| Jun 30, 2023 | -351,000.00 |
| Mar 31, 2023 | -248.26 Mn |
| Dec 31, 2022 | -232.60 Mn |
| Sep 30, 2022 | -219.03 Mn |
| Jun 30, 2022 | -209.20 Mn |
| Mar 31, 2022 | -199.78 Mn |
| Dec 31, 2021 | -188.60 Mn |
| Sep 30, 2021 | -175.97 Mn |
| Jun 30, 2021 | -168.14 Mn |